Hims (HIMS): FY25 Q1 earnings call, May 5, 2025
No Kalshi or Polymarket word markets were listed for Hims’s May 5, 2025 earnings call (FY25 Q1). The transcript is searchable below (quotes of at most 25 words).
UpdatedTranscript
quotes of at most 25 wordsSpeaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.
10 matches for “Collaboration”; 5 quoted, at least 25 words apart.
…specialties. We've added liraglutide earlier this year, and now through our new collaboration with Novo Nordisk, we're expanding access to branded Wegovy to bring subscribers…
…more people and helping them stay on track with their goals. This collaboration also signals something important, trust from a major pharmaceutical leader, and it…
…of those customers. We look forward to providing future updates as this collaboration and others like it continue to evolve. When we look towards the…
…to an expanding portfolio of solutions through the start of a long-term collaboration with Novo Nordics, one of the most respected companies in medical innovation.…
…investor base. We received quite a few questions on our recently announced collaboration with Novo Nordisk. This is a multi-part question from both the Hims…
Agents: this page as TSV at /api/v1/appearances/hims:2025-05-05:earnings_call · words: /api/v1/brief?appearance=hims:2025-05-05:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP